USANA Health Sciences Inc Stock News

Key Prominent Players Covered in the Immune Health Supplements Market Research Report Are Herbalife Nutrition (California, United States) ,Nutramax Laboratories (Maryland, United States) ,BioGaia (Stockholm, Sweden) ,Blackmores Limited (New South Wales, Australia) ,Glanbia, Plc (Kilkenny, Ireland) , Royal DSM (Heerlen, Netherlands) , Alticor Inc. (Amway) (Michigan, United States) ,USANA Health Sciences (Utah, United States) , Bayer AG (Leverkusen, Germany) , NOW Foods (Illinois, United States) , Pfizer (New York, United States) ,Other key market players Key Prominent Players Covered in the Immune Health Supplements Market Research Report Are Herbalife Nutrition (California, United States) ,Nutramax Laboratories (Maryland, United States) ,BioGaia (Stockholm, Sweden) ,Blackmores Limited (New South Wales, Australia) ,Glanbia, Plc (Kilkenny, Ireland) , Royal DSM (Heerlen, Netherlands) , Alticor Inc. (Amway) (Michigan, United States) ,USANA Health Sciences (Utah, United States) , Bayer AG (Leverkusen, Germany) , NOW Foods (Illinois, United States) , Pfizer (New York, United States) ,Other key market players

USANA Health Sciences, Inc. (NYSE:USNA) insider David Mulham Mulham sold 569 shares of the company’s stock in a transaction that occurred on Monday, November 15th. The shares were sold at an average price of $102.00, for a total value of $58,038.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which […]

Charles Schwab Investment Management Inc. grew its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 5.0% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 131,600 shares of the companys stock after buying an additional 6,251 shares during the quarter. Charles Schwab Investment Management Inc.s holdings in USANA Health Sciences were worth $13,480,000 at []

Q3 results were mixed. We see stock buying opportunity with 35% upside. USANA has a 47% market presence in rapidly-growing China.

USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q3 2021 Results - Earnings Call Transcript

USANA Health (USNA) delivered earnings and revenue surprises of 4.62% and 2.10%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Usana Health Sciences (NYSE:USNA) reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:17 PM. Here's what investors need to know about the announcement.

SALT LAKE CITY, Oct. 18, 2021 /PRNewswire/ -- USANA, a leader in cellular nutrition, proudly announces that its Coenzyme Q10 (CoQ10) supplement — CoQuinone 30 — has received the prestigious seal

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced the appointment of Xia Ding to the company's board of directors effective October 11, 2021. Ms. Ding currently

SALT LAKE CITY, Oct. 10, 2021 /PRNewswire/ -- On World Mental Health Day Sunday, Oct. 10, six key actions can help provide balance during the ongoing pandemic. Bestselling author and international spe

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2021 results will be released after the close of market on Tuesday, October 26, 2021. Shortl

USANA had record second-quarter results with +42% EPS growth on +30% sales.

When screening the market for stocks that are trading at or below their fair prices, one tool investors can use is the earnings power value (EPV).

SALT LAKE CITY, Sept. 27, 2021 /PRNewswire/ -- USANA congratulates Peggie Pelosi, a member of its board of directors, for being named one of the most influential leaders in the boardroom by the Nati

According to the Buffett-Munger Screener, one of several predefined screens available to GuruFocus Premium members, five stocks with good business fundamentals and are trading at attractive GF Values